Tilray Brands (TLRY) Short-term Investments (2018 - 2026)
Tilray Brands (TLRY) posted Short-term Investments of $15.3 million for Q1 2026, down 65.86% on a QoQ basis from $44.8 million in Q4 2025.
Tilray Brands (TLRY) Short-term Investments (2018 - 2026) Analysis & Trends
Tilray Brands' Short-term Investments history runs 8 years deep, the most recent figure standing at $15.3 million for Q1 2026.
- Quarterly Short-term Investments changed N/A year-over-year to $15.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $15.3 million (changed N/A YoY) and the FY2025 annual result came in at $34.7 million, up 7.81% from the prior year.
- Short-term Investments was $15.3 million for Q1 2026 at Tilray Brands, down from $44.8 million in the prior quarter.
- Across five years, Short-term Investments topped out at $243.3 million in Q4 2022 and bottomed at $1.6 million in Q3 2023.
- A 5-year average of $86.2 million and a median of $62.6 million in 2024 frame the typical range for Short-term Investments.
- Peak annual rise in Short-term Investments reached 4541.6% in 2024, while the deepest fall reached 67.28% in 2024.
- Tilray Brands' Short-term Investments stood at $243.3 million in 2022, then tumbled by 52.15% to $116.4 million in 2023, then tumbled by 46.27% to $62.6 million in 2024, then decreased by 28.3% to $44.8 million in 2025, then tumbled by 65.86% to $15.3 million in 2026.
- Business Quant data shows TLRY's Short-term Investments at $15.3 million in Q1 2026, $44.8 million in Q4 2025, and $34.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 15.31 Mn |
| Nov 30, 2025 | 44.85 Mn |
| May 31, 2025 | 34.70 Mn |
| Nov 30, 2024 | 62.55 Mn |
| Aug 31, 2024 | 74.87 Mn |
| May 31, 2024 | 32.18 Mn |
| Feb 29, 2024 | 79.61 Mn |
| Nov 30, 2023 | 116.42 Mn |
| Aug 31, 2023 | 1.61 Mn |
| Feb 28, 2023 | 243.29 Mn |
| Nov 30, 2022 | 243.29 Mn |
| Mar 31, 2020 | 20.08 Mn |
| Dec 31, 2019 | 25.49 Mn |
| Sep 30, 2019 | 22.21 Mn |
| Mar 31, 2019 | 31.23 Mn |
| Dec 31, 2018 | 1.51 Mn |
| Sep 30, 2018 | 14.71 Mn |